Ledger.Open graph →
SEC Form D · filed July 13, 2020

Clene Nanomedicine, Inc

Offering
$7.0M
Sold
$6.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SALT LAKE CITY, UT
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (26)

John Stevens · Salt Lake City, UTDirectorShalom Jacobovitz · Salt Lake City, UTDirectorAlison Mosca · Salt Lake City, UTDirectorDavid Lisonbee · Salt Lake City, UTDirectorRobert Gay · Salt Lake City, UTDirectorReed Wilcox · Salt Lake City, UTDirectorRob Etherington · Salt Lake City, UTExec · DirectorChad Young · Salt Lake City, UTDirectorArie Abecassis · White Plains, NYDirectorT.J. Stouder · Fanwood, NJDirectorWilliam Fleming · Fanwood, NJDirectorDoug Kimmel · Fanwood, NJDirectorJoshua P. Tatum · Peachtree Corners, GADirectorJ. P. Bayliss · Ridgefield, CTExec · DirectorStephanie C. Arkof · Encino, CADirectorJeremy Doo · Wilton, CTDirectorRyan Lund · Austin, TXDirectorNathaniel Weiss · Cambridge, MADirectorHayfin HF GP LLC · London, United KingdomDirectorMark Tognolini · London, United KingdomDirectorTim Flynn · London, United KingdomDirectorDavid Rushford · London, United KingdomDirectorHoward Rowe · London, United KingdomDirectorHayfin Management Limited · London, United KingdomDirectorYoshiyuki Nakamura · Fletcher, NCExec · DirectorRyan Lund · Austin, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗